Stratpharma at Music City SCALE 2026 in Nashville

Let’s connect at ONS 2026 in San Antonio! Stratpharma is pleased to participate in the Oncology Nursing Society (ONS) Congress 🎉 🗓 Date: 14-16 May📍Location: San Antonio, Texas🎯 Visit us at Booth: 230 We look forward to meeting oncology professionals and sharing our latest topical innovations in radiotherapy and oncology supportive care.

Together with Aesthetic Everything CEO Vanessa Florez, our Wound Care Specialist Jennifer Hoover were invited to the Sonoran Living show of Arizona local TV channel ABC 15 (USA). They had a chance to talk about our two film-forming wound dressings which can be used directly on open wounds to improve healing and aesthetic results –…

Stratpharma is pleased to participate in the European Society for Radiotherapy and Oncology (ESTRO) Congress 2026 🎉 🗓 Date: 15-18 May📍 Location: Stockholmsmässan, Stockholm🎯 Visit us at Booth: C15:81 (hall C) Join us as we showcase how our innovative solutions are enhancing oncology patient care and improving quality of life worldwide.

Stratpharma at 2026 Annual Meeting of the Swiss Society of Neonatology – Meet us in Aarau! 🚀 We are pleased to announce that Stratpharma Switzerland will be exhibiting at the Annual Meeting of the Swiss Society of Neonatology (SNN). ✨ 📆 May 19, 2026📍 Kultur & Kongresszentrum, Aarau

The Cosmetic Surgery Forum recently asked some of their top Key Opinion Leaders in the industry to share their Top 5 Vendors with whom they work with, who have brought significant value to their business and patient experience. From “help managing changes in coding regulations to device companies whose work and research have meaningfully impacted…

San Diego, California Oct 20, 2023 (The content of this article comes exclusively from the website Issuewire.com) Stratpharma AG, a Swiss-based global leader specializing in innovative topical medical devices for enhancing Oncology Supportive Care, Dermatology, Plastic Surgery, Wound Care and Women’s Health, today announced the appointment of Jeff Wellman as the Chief Commercial Officer for…